Back to Search
Start Over
Cancer News Round-up.
- Source :
- PharmaWatch: Monthly Review; Apr2008, Vol. 7 Issue 4, p4-5, 2p
- Publication Year :
- 2008
-
Abstract
- The article offers news briefs related to cancer therapy. Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals Inc. have cut their Phase III trial of Nevaxar for non-small cell lung cancer. The Horizon III Phase II/III study of Recentin in patients with first line metastatic colorectal cancer by AstraZeneca PLC will progress into Phase III. Next generation anticancer compounds of PhytoMedical Technologies Inc. were found to kill difficult-to-treat human cancer cells.
- Subjects :
- CANCER treatment
CLINICAL drug trials
ANTINEOPLASTIC agents
CANCER cells
Subjects
Details
- Language :
- English
- Volume :
- 7
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- PharmaWatch: Monthly Review
- Publication Type :
- Report
- Accession number :
- 31588530